Related Experiment Videos

Racial differences in blood pressure response to angiotensin-converting enzyme inhibitors in children: a

J S Li1, C M Baker-Smith, P B Smith

  • 1Office of Pediatric Therapeutics, Office of the Commissioner, US Food and Drug Administration, Rockville, Maryland, USA. jennifer.li@duke.edu

Clinical Pharmacology and Therapeutics
|June 13, 2008
PubMed

Insights

Angiotensin-converting enzyme (ACE) inhibitors effectively lower blood pressure in children by altering vasoactive substances. This study used meta-analysis to explore how race impacts their effectiveness in pediatric hypertension treatment.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Pharmacology

Background:

  • Angiotensin-converting enzyme (ACE) inhibitors are a common treatment for pediatric hypertension.
  • These drugs modulate the renin-angiotensin-aldosterone system and bradykinin pathways.
  • ACE inhibitors reduce systemic vascular resistance and promote sodium excretion without affecting heart rate.

Purpose of the Study:

  • To evaluate the efficacy of ACE inhibitors in pediatric hypertension.
  • To determine the influence of race on blood pressure response to ACE inhibitors in children.

Main Methods:

  • A meta-analysis was performed on data from six clinical trials involving ACE inhibitors in children.
  • Statistical techniques were employed to analyze blood pressure changes and assess racial variations.

Main Results:

  • ACE inhibitors demonstrated a significant effect on blood pressure reduction in the pediatric population.
  • Preliminary analysis suggests potential differences in response based on race, warranting further investigation.

Conclusions:

  • ACE inhibitors are a viable therapeutic option for managing hypertension in children.
  • Race may be a factor influencing the blood pressure response to ACE inhibitors in pediatric patients, highlighting the need for personalized treatment approaches.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Blood Pressure01:24

Blood Pressure

The movement of blood in a human body, commonly referred to as blood flow, is determined by the volume of blood that traverses a certain section of the bodily system per unit time. It is the rhythmic contraction of the heart's ventricles that primarily instigates this movement. As the ventricles contract, blood is forced into the prominent arteries, which then flow from areas of greater pressure to lower pressure areas. This movement continues into smaller arteries and arterioles and...